NASDAQ : ENLV

Enlivex Therapeutics Ltd.

$5.84 USD

-$0.21 (-3.47%)

Volume
116.92K
Average Volume
31.57K
Market Capitalization
$98.3M
P/E Ratio
0.01
Dividend Yield
0.00%
Price Target
$15.00
Year High
$31.50
Year Low
$5.41
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$193.24

NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)

0

NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)

0

AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)

-$

ENLV Estimated and Actual Revenue by Quarter

Get MSFT Insider Trade Alerts

ENLV Insider Trading History

Insider Name Title Date Transaction Cost Filing Date
Hershkovitz Oren officer: Chief Executive Officer 2026-03-18 0 2026-03-18
Hershkovitz Oren officer: Chief Executive Officer 2023-11-16 8.19 2026-03-18
Hershkovitz Oren officer: Chief Executive Officer 2025-11-24 5.34 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2026-03-18 0 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2021-03-07 2.69 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2021-12-12 6.22 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2024-03-30 4.68 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2022-12-10 10.12 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2025-11-24 3.21 2026-03-18
Shlosberger Shachar officer: Chief Financial Officer 2025-11-24 5.34 2026-03-18
Hart Gili director 2026-03-18 0 2026-03-18
Hart Gili director 2019-06-01 2.69 2026-03-18
Hart Gili director 2026-03-18 5.34 2026-03-18
NOVIK SHAI A director 2026-03-18 0 2026-03-18
NOVIK SHAI A director 2021-12-12 6.22 2026-03-18
NOVIK SHAI A director 2023-05-03 3.66 2026-03-18
NOVIK SHAI A director 2024-05-28 12.23 2026-03-18
NOVIK SHAI A director 2025-11-17 5.34 2026-03-18
NOVIK SHAI A director 2019-06-01 2.69 2026-03-18
Pomerantz Roger director 2026-03-18 0 2026-03-18
Pomerantz Roger director 2026-03-18 5.967 2026-03-18
Havron Avraham director 2026-03-18 0 2026-03-18
Havron Avraham director 2019-06-01 2.69 2026-03-18
Havron Avraham director 2026-03-18 5.34 2026-03-18
Galamidi Einat officer: Chief Medical Officer 2026-03-18 0 2026-03-18
Galamidi Einat officer: Chief Medical Officer 2025-11-24 5.34 2026-03-18
Galamidi Einat officer: Chief Medical Officer 2025-11-24 3.21 2026-03-18
Murray Michael Anthony other: former SVP - Operations 2015-10-09 S-Sale 2.78 2015-10-27
WEATHERSON HARVEY D director 2008-01-02 A-Award 1.25 2008-01-04
RANEY DENNIS R director 2008-01-02 A-Award 1.25 2008-01-04